Ruxandra Draghia-Akli

This inventor holds 28 USPTO granted patents and 1 published patent application, plus 17 CIPO patents and 6 EPO patents, primarily in Vaccine Development. Top assignees: Vgx Pharmaceuticals, Inc., University of Pennsylvania, Inovio Pharmaceuticals, Inc.. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ruxandra Draghia-Akli. Retrieved from https://idiyas.com/inventor/ruxandra-draghia-akli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 1)

% Patents Active = 96.4

CIPO Patents = 17 (Patent Applications = 1)

EPO Patents = 6

Average Co-Inventor Count = 2.9

ph-index = 7

Forward Citations = 301(Granted Patents)

Location History:

The Woodlands, TX (US) (2008)
Brussels, BE (2012 - 2018)
Houston, TX (US) (2002 - 2022)

Company Filing History:

14 out of 18

Vgx Pharmaceuticals, Inc.

patents

8 out of 2,659

University of Pennsylvania

patents

5 out of 93

Inovio Pharmaceuticals, Inc.

patents

4. 3 out of 619

Baylor College of Medicine

7. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...

Areas of Expertise:

Vaccine

Influenza Virus

Electroporation

Plasmids

Gene Therapy

Antibody Production

HCV Vaccines

GHRH

Therapeutic Applications

Growth Hormone

Immunotherapy

Synthetic Biology

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11453855 - Compositions comprising high concentration of biologically active molecules and processes for preparing the same (2022-09-27),

2. 10076565 - Vaccines against multiple subtypes of influenza virus (2018-09-18),

3. 9592285 - Vaccines against multiple subtypes of influenza virus (2017-03-14),

4. 9452285 - Electroporation devices and methods of using same for electroporation of cells in mammals (2016-09-27),

5. 9156891 - Vaccines and methods for using the same (2015-10-13),

6. 9156890 - HCV vaccines and methods for using the same (2015-10-13),

7. 8962818 - Compositions comprising GHRH and GnRH and methods of using the same (2015-02-24),

8. 8927508 - Antibody production elicited by a DNA vaccine delivered by electroporation (2015-01-06),

9. 8921536 - HCV vaccines and methods for using the same (2014-12-30),

10. 8829174 - HCV vaccines and methods for using the same (2014-09-09),

11. 8563302 - Optimized high yield synthetic plasmids (2013-10-22),

12. 8535687 - Smallpox DNA vaccine and the antigens therein that elicit an immune response (2013-09-17),

13. 8481504 - Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications (2013-07-09),

14. 8209006 - Constant current electroporation device and methods of use (2012-06-26),

15. 8188056 - Reducing arthritis and lameness in subjects by growth hormone releasing hormone (GHRH) supplementation (2012-05-29),

Title: The Innovative Journey of Ruxandra Draghia-Akli

Introduction: Ruxandra Draghia-Akli is a pioneering inventor based in Houston, TX, known for her groundbreaking work in the field of biotechnology and medical research.

Latest Patents: Ruxandra Draghia-Akli holds several patents related to novel gene therapies and personalized medicine, showcasing her commitment to advancing healthcare through innovation.

Career Highlights: With a distinguished career spanning over two decades, Draghia-Akli has held key research positions in renowned institutions, contributing significantly to the development of cutting-edge medical technologies.

Collaborations: Throughout her career, Draghia-Akli has collaborated with leading scientists, medical professionals, and biotech companies to bring innovative solutions from the lab to the market, further solidifying her reputation as a trailblazer in the field.

Conclusion: Ruxandra Draghia-Akli's relentless pursuit of innovation and her dedication to improving healthcare have cemented her status as a prominent figure in the world of biotechnology and medical research.

Profile summary based on public USPTO records.